Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not.
Syncona buys gene therapy company; Oryzon’s €45M financing agreement; InDex scraps PhIII drug
Syncona scoops up Freeline: British life sciences investor Syncona said Wednesday it agreed to buy gene therapy maker Freeline Therapeutics through a new portfolio company.